Stocks · Korea
007370
KOSDAQ
JIN Yang Pharmaceutical
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
PER2.20x
PBR0.35x
EPS1,828 KRW
BPS11,310 KRW
ROE13.93%
Dividend yield3.74%
DPS150 KRW
Payout ratio8.21%
Returns and 52-week range
1W-0.12%
1M+0.00%
3M+6.22%
6M-11.27%
1Y-32.52%
YTD-20.81%
52W high5,980원
52W low3,350원
From 52W high-32.86%
Financial results (separate)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 763억 | 111억 | 123억 | 14.6% |
| 2023 | 941억 | 91억 | 127억 | 9.7% |
| 2024 | 1,133억 | 117억 | 297억 | 10.3% |
| 2025 | 1,207억 | 25억 | 223억 | 2.1% |
| Quarterly | ||||
| 2024 4Q | 268억 | 31억 | 25억 | 11.5% |
| 2025 1Q | 309억 | 38억 | 23억 | 12.4% |
| 2025 2Q | 302억 | 25억 | 17억 | 8.2% |
| 2025 3Q | 292억 | -9억 | -10억 | -3.2% |
| 2025 4Q | 303억 | -29억 | 193억 | -9.4% |
| 2026 1Q | 324억 | 34억 | 23억 | 10.4% |
Company
Address: 서울특별시 서초구 효령로 231
Peers in the same sector
Recent filings
- 2026-08-13반기보고서 (2026.06)
- 2026-05-15분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.